## Abstract ## Background Rats with experimental Parkinson's disease (PD) are treated with intravenous glial‐derived neurotrophic factor (GDNF) plasmid DNA, non‐viral gene therapy using Trojan horse liposomes (THLs) targeted with a monoclonal antibody (MAb) to the rat transferrin receptor (TfR). E
Tyrosine hydroxylase replacement in experimental Parkinson’s disease with transvascular gene therapy
✍ Scribed by Pardridge, William M.
- Book ID
- 119923113
- Publisher
- American Society for Experimental NeuroTherapeutics
- Year
- 2005
- Tongue
- English
- Weight
- 723 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1545-5343
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Tyrosine hydroxylase (TH) gene is the ratelimiting enzyme in the synthesis of catecholamines. Functional polymorphisms of the TH gene may be involved in the pathogenesis of neuropsychiatric diseases such as schizophrenia, affective disorders, and Parkinsonism. This study examined a possible associat
## Abstract Impaired debrisoquine metabolism resulting from defects in the cytochrome P450 __CYP2D6__‐debrisoquine hydroxylase gene has been shown to be associated with the development of Parkinson's disease(PD). We studied two polymorphisms in this gene in 207 Chinese PD patients and 227 control s